Literature DB >> 23709152

Total pancreatectomy for recurrent intraductal papillary mucinous carcinoma in remnant pancreas of pancreaticoduodenectomy for intraductal papillary mucinous adenocarcinoma.

Yu Ohkura1, Kazunari Sasaki, Masamichi Matsuda, Masaji Hashimoto.   

Abstract

A 62-year-old man underwent pancreaticoduodenectomy (PD) for intraductal papillary mucinous carcinoma (IPMC) in 2006. No signs of adenocarcinoma at the resection margin were found by intraoperative pathological examination of frozen sections. The postoperative pathological diagnosis was invasive carcinoma derived from IPMC and moderately differentiated tubular adenocarcinoma. A blood analysis in 2011 showed serum (CA19-9) to be increased since the initial resection. Imaging test showed a recurrent tumour at the site of the pancreaticogastrostomy (PG) in the remnant pancreas. We conducted total remnant pancreatectomy for recurrent IPMC and partial gastrectomy. Because both lesions had a histopathological resemblance, the pathological diagnosis was recurrent invasive IPMC. Based on this experience, it is important to facilitate early detection by annual check-up. And also, we recommend PG as a reconstructive intervention in patients at high risk of IPMC recurrence in the remnant pancreas following PD as it is grossly visible on upper gastrointestinal endoscopy.

Entities:  

Mesh:

Year:  2013        PMID: 23709152      PMCID: PMC3670023          DOI: 10.1136/bcr-2013-009856

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  11 in total

Review 1.  International consensus guidelines for management of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas.

Authors:  Masao Tanaka; Suresh Chari; Volkan Adsay; Carlos Fernandez-del Castillo; Massimo Falconi; Michio Shimizu; Koji Yamaguchi; Kenji Yamao; Seiki Matsuno
Journal:  Pancreatology       Date:  2006       Impact factor: 3.996

2.  Study of recurrence after surgical resection of intraductal papillary mucinous neoplasm of the pancreas.

Authors:  Suresh T Chari; Dhiraj Yadav; Thomas C Smyrk; Eugene P DiMagno; Laurence J Miller; Massimo Raimondo; Jonathan E Clain; Ian A Norton; Randall K Pearson; Bret T Petersen; Maurits J Wiersema; Michael B Farnell; Michael G Sarr
Journal:  Gastroenterology       Date:  2002-11       Impact factor: 22.682

3.  Intraductal papillary mucinous adenocarcinoma of the pancreas: clinical outcomes, prognostic factors, and the role of adjuvant therapy.

Authors:  Brian M Alexander; Carlos Fernandez-Del Castillo; David P Ryan; Lisa A Kachnic; Aram F Hezel; Andrzej Niemierko; Christopher G Willett; Kevin R Kozak; Lawrence S Blaszkowsky; Jeffrey W Clark; Andrew L Warshaw; Theodore S Hong
Journal:  Gastrointest Cancer Res       Date:  2011-07

4.  Invasive intraductal papillary mucinous carcinomas of the pancreas: predictors of survival and the role of lymph node ratio.

Authors:  Stefano Partelli; Carlos Fernandez-Del Castillo; Claudio Bassi; William Mantovani; Sarah P Thayer; Stefano Crippa; Cristina R Ferrone; Massimo Falconi; Paolo Pederzoli; Andrew L Warshaw; Roberto Salvia
Journal:  Ann Surg       Date:  2010-03       Impact factor: 12.969

5.  Clinicopathological features and treatment of intraductal papillary mucinous tumour of the pancreas.

Authors:  M Falconi; R Salvia; C Bassi; G Zamboni; G Talamini; P Pederzoli
Journal:  Br J Surg       Date:  2001-03       Impact factor: 6.939

6.  Prognosis of malignant intraductal papillary mucinous tumours of the pancreas after surgical resection. Comparison with pancreatic ductal adenocarcinoma.

Authors:  F Maire; P Hammel; B Terris; F Paye; J-Y Scoazec; C Cellier; M Barthet; D O'Toole; P Rufat; C Partensky; E Cuillerier; P Lévy; J Belghiti; P Ruszniewski
Journal:  Gut       Date:  2002-11       Impact factor: 23.059

7.  Pancreaticojejunostomy vs. pancreaticogastrostomy following pancreaticoduodenectomy: results of comparative study.

Authors:  A Makni; H Bedioui; M Jouini; F Chebbi; R Ksantini; F Fetirich; W Rebai; A Daghfous; S Ayedi; M Kacem; Z Ben Safta
Journal:  Minerva Chir       Date:  2011-08       Impact factor: 1.000

8.  WHO-classification 2000: exocrine pancreatic tumors.

Authors:  G Klöppel; J Lüttges
Journal:  Verh Dtsch Ges Pathol       Date:  2001

9.  Main-duct intraductal papillary mucinous neoplasms of the pancreas: clinical predictors of malignancy and long-term survival following resection.

Authors:  Roberto Salvia; Carlos Fernández-del Castillo; Claudio Bassi; Sarah P Thayer; Massimo Falconi; William Mantovani; Paolo Pederzoli; Andrew L Warshaw
Journal:  Ann Surg       Date:  2004-05       Impact factor: 12.969

10.  Pattern of recurrence after resection for intraductal papillary mucinous tumors of the pancreas.

Authors:  M Sho; Y Nakajima; H Kanehiro; M Hisanaga; K Nishio; M Nagao; N Ikeda; H Kanokogi; T Yamada; H Nakano
Journal:  World J Surg       Date:  1998-08       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.